HSP60 may Predict Good Pathological Response to Neoadjuvant Chemoradiotherapy in Bladder Cancer
Authors:
Open Access
- 9 November 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 37 (1) , 56-61
Abstract
Heat shock proteins (HSPs) play crucial roles in cellular responses to stressful conditions. Expression of HSPs in invasive or high-risk superficial bladder cancer was investigated to identify whether HSPs predict pathological response to neoadjuvant chemoradiotherapy (CRT). Immunohistochemistry was used to assess expression levels of HSP27, HSP60, HSP70, HSP90 and p53 in 54 patients with invasive or high-risk superficial bladder cancer, prior to low-dose neoadjuvant CRT, followed by radical or partial cystectomy. Patients were classified into two groups (good or poor responders) depending on pathological response to CRT, which was defined as the proportion of morphological therapeutic changes in surgical specimens. Good responders showed morphological therapeutic changes in two-thirds or more of tumor tissues. In contrast, poor responders showed changes in less than two-thirds of tumor tissues. Using a multivariate analysis, positive HSP60 expression prior to CRT was found to be marginally associated with good pathological response to CRT (P = 0.0564). None of clinicopathological factors was associated with HSP60 expression level. In the good pathological responders, the 5-year cause-specific survival was 88%, which was significantly better than survival in the poor responders (51%) (P = 0.0373). Positive HSP60 expression prior to CRT may predict good pathological response to low-dose neoadjuvant CRT in invasive or high-risk superficial bladder cancer.Keywords
This publication has 13 references indexed in Scilit:
- Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: A report from the Radiation Therapy Oncology GroupInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinomaEuropean Journal of Cancer, 2004
- Favorable Outcome of Preoperative Low Dose Chemoradiotherapy Against Muscle-Invasive Bladder CancerAmerican Journal of Clinical Oncology, 2003
- Can patient selection for bladder preservation be based on response to chemotherapy?Cancer, 2003
- Clinical significance of heat shock protein-70 expression in bladder cancerUrology, 2003
- Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell DeathJNCI: Journal of the National Cancer Institute, 2000
- Apoptosis, p53, bcl-2, and Ki-67 in invasive bladder carcinoma: possible predictors for response to radiochemotherapy and successful bladder preservationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacille Calmette–Guérin (BCG) in patients with superficial bladder cancerClinical and Experimental Immunology, 1997
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- Unusual expression and localization of heat‐shock proteins in human tumor cellsInternational Journal of Cancer, 1992